Ornithine transcarbamylase deficiency: a model for gene therapy.
作者信息
Morsy M A, Caskey C T
机构信息
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
出版信息
Adv Exp Med Biol. 1994;368:145-54. doi: 10.1007/978-1-4615-1989-8_15.
PMID:7741006
Abstract
摘要
相似文献
1
Ornithine transcarbamylase deficiency: a model for gene therapy.鸟氨酸转氨甲酰酶缺乏症：基因治疗的一个模型。
Adv Exp Med Biol. 1994;368:145-54. doi: 10.1007/978-1-4615-1989-8_15.
2
Fatal clinical course of ornithine transcarbamylase deficiency in an adult heterozygous female patient.
Digestion. 1997;58(1):83-6. doi: 10.1159/000201428.
3
Ornithine transcarbamylase deficiency: case report and review.鸟氨酸转氨甲酰酶缺乏症：病例报告与综述
Kans Med. 1995 Fall;96(3):135-8.
4
Identification of 'private' mutations in patients with ornithine transcarbamylase deficiency.
J Inherit Metab Dis. 1997 Aug;20(4):525-7. doi: 10.1023/a:1005301513465.
5
Symptomatic ornithine carbamoyltransferase deficiency (point mutation H202P) with normal in vitro activity.具有正常体外活性的症状性鸟氨酸氨甲酰基转移酶缺乏症（点突变H202P）
J Inherit Metab Dis. 1998 Feb;21(1):71-2. doi: 10.1023/a:1005315531630.
6
Fatal initial adult-onset presentation of urea cycle defect.尿素循环缺陷的致命性成人首发表现。
Arch Neurol. 2007 Dec;64(12):1777-9. doi: 10.1001/archneur.64.12.1777.
7
Hyperammonemia: a deficiency of liver ornithine transcarbamylase.高氨血症：肝脏鸟氨酸转氨甲酰酶缺乏。
Paediatr Univ Tokyo. 1970 Dec;18:167-73.
8
[Ornithine-transcarbamylase deficiency: prognostic difficulties].[鸟氨酸转氨甲酰酶缺乏症：预后困难]
An Esp Pediatr. 1991 Dec;35(6):407-8.
9
Genetic analysis of carbamoylphosphate synthetase I and ornithine transcarbamylase deficiency using fibroblasts.利用成纤维细胞对氨甲酰磷酸合成酶I和鸟氨酸转氨甲酰酶缺乏症进行基因分析。
Eur J Pediatr. 2001 May;160(5):283-7. doi: 10.1007/s004310100725.
10
Gene therapy in man and mice: adenosine deaminase deficiency, ornithine transcarbamylase deficiency, and Duchenne muscular dystrophy.人类和小鼠的基因治疗：腺苷脱氨酶缺乏症、鸟氨酸转氨甲酰酶缺乏症和杜氏肌营养不良症。
Adv Exp Med Biol. 1991;309B:51-6. doi: 10.1007/978-1-4615-7703-4_12.
Zotero 插件